Resectable Breast Carcinoma
3 clinical trials · Condition
◉ Watch Resectable Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer (NCT05447910) | Mayo Clinic | 2022-07-21 |
| Intravital Microscopy in Human Solid Tumors (NCT03823144) | Mayo Clinic | 2019-02-28 |
Track Resectable Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.